and a cost-effectiveness analysis is performed using reliable estimates of test sensitivity and specificity,as compared with the current iFOBT."
The current iFOBT is similar if not better than COLOSTAT. I have advised you before in a previous post but you are all in denial.
in all of RHY announcements they state the following
”Highly Accurate - ColoSTAT® was shown to be 35% more accurate at detecting colorectal cancer than the current market standard Faecal Immunochemical Test (FIT)
what is the current market standard? Please tell me how it relates to Australia.
ColoSTAT® was shown to be more accurate at detecting advanced adenomas than the current market standard Faecal Immunochemical Test (FIT)
More accurate by how much? Is it significant?
@josiejow37
RHY compare IFOBT to COLOSTAT from internal company data from study 7. That’s where they get send and spec comparisons from.
- Forums
- ASX - By Stock
- Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
RHY
rhythm biosciences limited
Add to My Watchlist
15.4%
!
6.0¢

and a cost-effectiveness analysis is performed using reliable...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
0.008(15.4%) |
Mkt cap ! $17.04M |
Open | High | Low | Value | Volume |
5.2¢ | 6.0¢ | 5.2¢ | $21.32K | 381.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 198929 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 248871 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 198929 | 0.056 |
1 | 98789 | 0.055 |
1 | 20507 | 0.054 |
1 | 97 | 0.051 |
6 | 547611 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 248871 | 4 |
0.062 | 43127 | 1 |
0.065 | 5377 | 1 |
0.075 | 88927 | 1 |
0.080 | 38871 | 2 |
Last trade - 15.42pm 04/07/2025 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online